What's Going on in the Trials?

3min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

The first trials were in tens of 16 and 17 year olds. Now ena may be weon look into younger age groups, so under 12 down all the way to children as young as six months. Those trials are going to be run pretty differently from the trials in adults,. And even the trial and in adolescence. So far, early results are good.

As COVID-19 vaccine roll-outs continue, attentions are turning to one group: children. While research suggests that children rarely develop severe forms of COVID-19, scientists still believe they could play a key role in transmission and a plan needs to be in place for the longer term. But clinical trials in children are more complicated than those in adults as different ethical and practical concerns need to be taken into account.

In this episode of Coronapod, we discuss the ongoing clinical trials to test vaccines in young children, and ask what scientists want to know about safety, and how effective these vaccines might be at preventing disease and transmission.

News: COVID vaccines and kids: five questions as trials begin

Hosted on Acast. See acast.com/privacy for more information.